Accelerate Diagnostics, Inc. engages in the research and development and commercialization of proprietary surface chemistry formulation and quantitative bio-analytical measurement instruments. The company is developing BACcel system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was formerly known as Accelr8 Technology Corp. and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.